Essential role of pepsin in pathogenesis of acid reflux esophagitis in rats

Digestive Diseases and Sciences

Volumn 51, Issue 2, 2006, Pages 303-309

  Nagahama, Kenji ^a   Yamato, Masanori ^a   Nishio, Hikaru ^a   Takeuchi, Koji ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Acid reflux esophagitis; L glutamine rat model; Pathogenesis; Pepsin

Indexed keywords

12 SULFODEHYDROABIETIC ACID; ANTIULCER AGENT; CIMETIDINE; GLUTAMINE; LAFUTIDINE; OMEPRAZOLE; PEPSIN A; PEPSTATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; ESOPHAGUS INJURY; FORESTOMACH; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PYLORUS LIGATION; RAT; REFLUX ESOPHAGITIS; STOMACH PH;

ANIMALS; ANTI-ULCER AGENTS; DISEASE MODELS, ANIMAL; ESOPHAGITIS, PEPTIC; ESOPHAGUS; GLUTAMINE; MALE; PEPSIN A; PEPSTATINS; PROTEASE INHIBITORS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 33644883925     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-006-3129-8     Document Type: Article

References (19)

1. DeMeester TR, Wernly JA, Bryant GH, Little AG, Skinner DB: Clinical and in vitro analysis of determinants of gastroesophageal competence: A study of the principles of antireflux surgery. Am J Surg 137:39-46, 1979
2. Hunt RH: Importance of pH control in the management of GERD. Arch Intern Med 159:649-657, 1999
3. 2-receptor antagonist. Scand J Gastroenterol 23 (Suppl 146):201-213, 1988
4. 2-receptor antagonists. Scand J Gastroenterol 24 (Suppl 166):88-93, 1989
5. Inatomi N, Nagaya H, Takami K, Shino A, Satoh H: Effects of a proton pump inhibitor, AG-1749 (lansoprazole), on reflux esophagitis and experimental ulcers in rats. Jpn J Pharmacol 55:437-451, 1991
6. Hirschowitz BI: Pepsin and esophagitis. Yale J Biol Med 72:133-143, 1991
7. Lanas AI, Blas JM, Ortego J, Soria J, Sainz R: Adaptation of esophageal mucosa to acid- and pepsin-induced damage: role of nitric oxide and epidermal growth factor. Dig Dis Sci 42:1003-1012, 1997
8. Goldberg HI, Dodds WJ, Gee S, Montgomery C, Zboralske FF: Role of acid and pepsin in acute experimental esophagitis. Gastroenterology 56:223-230, 1969
9. Umezawa H, Aoyagi T, Morishima H, Matsuzaki M, Hamada M, Takeuchi T: Pepstatin, a new pepsin inhibitor produced by actinomycetes. J Antibioti 23:259-262, 1970
10. Kunimoto S, Aoyagi T, Morishima H, Takeuchi T, Umezawa H: Mechanism of inhibition of pepsin by pepstatin J. Antibiot 25:251-255, 1972
11. Okabe S, Takeuchi K, Takata Y, Naganuma T, Takagi K: Effects of L-glutamine on various gastric lesions in rats and guinea pigs. Digestion 14:325-331, 1976
12. Salo JA, Lefto VP, Kivilaakso E: Morphologic alterations in experimental esophagitis: light microscopic and scanning and transmission electron microscopic study. Dig Dis Sci 28:440-448, 1983
13. 2-receptor antagonist, on reflux esophagitis in rats through capsaicin-sensitive afferent neurons. J Pharmacol Sci 93:55-61, 2003
14. Anson ML: The estimation of pepsin, trypsin, papain and cathepsin with hemoglobin. J Gen Physiol 22:79-89, 1938
15. Klinkenberg-Knol EC, Nelis F, Dent J, Snel P, Mitchell B, Prichard P, Lloyd D, Havu N, Frame MH, Roman J, Walan A, Group LT: Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa. Gastroenterology 118:661-669, 2000
16. Onoda Y, Magaribuchi T, Tamaki H: Effect of 12-sulfodehydroabietic acid monosodium salt (TA-2711), a new anti-ulcer agent, on gastric secretion and experimental ulcers in rats. Jpn J Pharmacol 51:65-73, 1989
17. Kinoshita M, Endo M, Yasoshima A, Saito N, Yamasaki K, Chishima S, Narita H. Ecabet sodium, a novel locally-acting anti-ulcer agent, protects the integrity of the gastric mucosal gel layer from pepsin-induced disruption in the rat. Aliment Pharmacol Ther 13:687-694, 1999
18. Okabe S, Takeuchi K, Nakamura K, Takagi K: Pathogenesis of gastric lesions induced by aspirin in the pylorus-ligated rat. Jpn J Pharmacol 24:363-371, 1974
19. Hirschowitz BI: A critical analysis, with appropriate controls of gastric acid and pepsin secretion in clinical esophagitis. Gastroenterology 101:1149-1158, 1991